Sea Buckthorn for Cholesterol

Verdict: Sea buckthorn does not lower cholesterol

Sea buckthorn berry is safe to eat as a food, but human trials show it does not meaningfully lower total cholesterol, LDL, HDL, or triglycerides, so it should not be used to manage blood lipids. EU regulators have formally rejected its cholesterol and cardiovascular health claims.

U ⚫ U Unverified Counter-Evidence

🔬Why this grade7-layer evidence engine

Four small-to-moderate randomized controlled trials (combined n约396) consistently found no significant effect on the standard lipid panel. An 8-week juice trial in healthy men (PMID 12088800), the largest cohort using 28 g/day freeze-dried berries (PMID 17593932), berry oil over 4 weeks (PMID 11120446), and a 13-week trial in overweight women (PMID 23945716) all reported neutral total cholesterol, LDL, HDL, and triglyceride results. No meta-analysis, systematic review, or long-term cardiovascular outcome trial exists.

Regulators and major clinics reinforce this. The EU's EFSA has rejected sea buckthorn's blood-cholesterol and cardiovascular health claims because a cause-and-effect relationship was not established. The US FDA recognizes the berry only as GRAS, which is a food-safety status and not an efficacy endorsement, while the NHS, WHO, NIH Office of Dietary Supplements, Mayo Clinic, Cleveland Clinic, Harvard Health, and the AHA/NLA do not list it among evidence-based cholesterol options.

One caveat is worth flagging: the single n=12 berry-oil study (PMID 11120446) noted a modest rise in fasting blood glucose alongside reduced platelet aggregation. This signal is statistically fragile but underpins a Grade F rating for blood glucose, so people with type 2 diabetes, insulin resistance, or those on anticoagulants should be cautious. Overall the evidence is graded Unverified / Counter-Evidence: sea buckthorn does not work for cholesterol.

⚖️

Scoring transparency

All scores computed by a 7-layer evidence engine — fully auditable
Raw score 0.35
D
C
B
A
S
← counter-evidence / ineffectiveeffective / strong evidence →
Final grade
U · Counter-Evidence
Confidence
77%
Broadly consistent
Evidence level
E6
Multiple smaller RCTs (n<500)

How strongly each layer supports this effect

lower = less supportive
L2 PubMedPrimary literature
0.20
L11 AI re-checkIndependent read
0.30
L1 ExamineGlobal benchmark
0.50
L3 MechanismPlausibility
0.50
L5 Clinical bodiesAuthoritative stance
0.50
Against Mixed Supports
View the full decision path (audit trail)
  1. compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.351
  2. tier_from_score — 依分數區間映射至 tier letter
  3. apply_hec_rules — 無高階證據可裁決
  4. tier_strict_requirement_check — D 級條件未達 (需 E1-E3 negative;實際 E6)
  5. detect_disputes — 偵測到 0 個 hard + 0 個 soft dispute
  6. decide_status — 依 tier + dispute 結果決定 status

📄PubMed studies (4)L2 · primary research & systematic reviews

Effects of an antioxidant-rich juice (sea buckthorn) on risk factors for coronary heart disease in humans
PMID: 12088800 2002 隨機對照試驗 n = 20
Finding: No significant change in total cholesterol, LDL-C, HDL-C, or triglycerides versus placebo. Plasma vitamin C and ex-vivo LDL oxidation resistance increased; modest rise in HDL within sea buckthorn arm did not reach significance vs control.
🟠 Limited quality Academic
View on PubMed
Effects of sea buckthorn berries on infections and inflammation: a cluster randomized, double-blind, placebo-controlled trial
PMID: 17593932 2009 RCT (double-blind) n = 254
Finding: Sea buckthorn berries did not significantly affect serum total cholesterol, LDL-C, HDL-C, or triglycerides versus placebo over 90 days; a secondary sub-analysis of the same cohort (Larmo 2013) showed flavonol intake rose but lipid endpoints were neutral.
Mixed funding
View on PubMed
Sea buckthorn berry oil inhibits platelet aggregation
PMID: 11120446 2000 隨機對照試驗 n = 12
Finding: Platelet aggregation reduced (small decrease). Total cholesterol, LDL-C, HDL-C and triglycerides were unchanged vs. control. Fasting blood glucose increased modestly within the SB arm (signal of small detriment) — this is the n=12 study Examine cites for Grade D (lipids) and Grade F (blood glucose).
🟠 Limited quality Academic
View on PubMed
Effects of sea buckthorn and bilberry on serum metabolites differ according to baseline metabolic profiles in overweight women
PMID: 23945716 2013 隨機對照試驗 n = 110
Finding: No statistically significant overall effect on standard lipid panel (TC, LDL-C, HDL-C, TG); subgroup analysis suggested baseline-dependent shifts in VLDL particle composition in metabolically unhealthy women, but primary lipid endpoints were neutral.
Academic
View on PubMed

🏛️Regulatory & authoritative positionsL4/L5 · FDA / EMA / NIH ODS / Cochrane / Mayo …

L4a US FDA
Supportive
Based on the information provided by SBR Group, Inc. (SBR), as well as other information available to FDA, the agency has no questions at this time regarding SBR's conclusion that sea buckthorn (Hippophae rhamnoides L.) berry, berry juice, and berry puree are GRAS under the intended conditions of use. source↗
L4b EU EFSA
Against
L4d TW TFDA / 衛福部
Neutral
食品不得為醫療效能之標示、宣傳或廣告……食品標示、宣傳或廣告不得有不實、誇張或易生誤解之情形(《食品安全衛生管理法》第28條)。 source↗
PMID 100% verifiedevery citation checked via NCBI Entrez
🔬4 PubMed studiesindependently re-checked by multiple sub-agents
engine_version: v1.0 claim_id: CLM-COND-cholesterol-INT-sea-buckthorn-001 繁體中文版 →